Pacific Biosciences (PACB) Releases Software Upgrade To Support Full-Length Transcript Sequencing And HLA Haplotype Phasing
3/31/2014 9:38:58 AM
MENLO PARK, Calif., March 31, 2014 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc., (Nasdaq:PACB) provider of the PacBio® RS II, today announced the release of a software upgrade for its Single Molecule, Real-Time (SMRT®) DNA Sequencing platform. SMRT Analysis 2.2 provides enhanced functionality to support two additional applications that uniquely benefit from the company's long-read sequencing technology: Iso-Seq™ full-length transcript/isoform sequencing, and human leukocyte antigen (HLA) haplotype phasing.
Help employers find you! Check out all the jobs and post your resume.
comments powered by